Article
β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression.
Human cell - 1 Jul 2024
Wang Ruoyu, Tang Dan, Ou Longyun, Jiang Jiacheng, Wu Yu-Nan, Tian Xuefei
Abstract excerpt
To explore the effects of β-Sitosterol upon hepatocellular carcinoma cell proliferation, apoptosis, migration, invasion, and epithelial-mesenchymal transition (EMT), and to investigate the underlying mechanism using network pharmacology. Human hepatocellular carcinoma cell lines (Huh-7 and HCCLM3) were expose to gradient concentrations of β-Sitosterol (5 μg/mL, 10 μg/mL, and 20 μg/mL). Cell viability and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
